Anatomical pathology instruments and consumables for cancer diagnostics
Epredia supplies tissue processing, microtomy, staining and slide products to pathology labs, backed by a regulated software stack (IEC 62304, ISO 13485) built on C#/.NET, WPF and C++ with HL7 and SNOMED for lab interoperability. Hiring is accelerating and sales-led, with engineering and manufacturing close behind, while job posts flag LIS/cloud interoperability and an unreliable CRM as live pain points.
Epredia is a precision cancer diagnostics company focused on anatomical pathology, formed in 2019 when PHC Group acquired the business from Thermo Fisher Scientific. Its portfolio spans tissue processing, cassette printing, embedding, sectioning, cryotomy, microscope slides and staining, sold to pathology laboratories. The company is headquartered in Portsmouth, New Hampshire, employs 1,001–5,000 people and is privately held. It recruits in the United States and the Netherlands, and runs commercial operations on Salesforce, SAP and ServiceMax with sales through direct and channel partner routes.
Epredia's stack includes C#, .NET, WPF, C++, React and Node.js, PostgreSQL and SQLite, HL7 and SNOMED for lab data, plus Salesforce, SAP, ServiceMax, Power BI and Incorta on the business side.
Yes, hiring is accelerating, led by sales with substantial engineering and manufacturing demand, mostly at mid-level, across the United States and the Netherlands.
Epredia is headquartered in Portsmouth, New Hampshire, United States, and has 1,001–5,000 employees.
Other companies in the same industry, closest in size
Epredia's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.